Loading stock data…

© 2026 Whystock · Bureau7 LLC. Intelligent Financial Insights.

Not financial advice. Data may be delayed. Use at your own risk.

Stock Glossary Popular Stocks Stock ScreenerPrivacy Terms

Why CTNM? Contineum Therapeutics, Inc. Analysis, Price & AI Insights | Whystock

CTNM

$13.20+0.38 (+2.96%)

Pre-Market$13.50+0.30 (+2.27%)· Last close May 1

Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications in the United States.

Overview Intraday ResearchPRO OptionsPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO

Intraday

Custom Range:

to

No data available for this range. Intraday data may be limited by the exchange.